Lauren Fong

1.5k total citations · 1 hit paper
14 papers, 1.0k citations indexed

About

Lauren Fong is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lauren Fong has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Lauren Fong's work include CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and CRISPR and Genetic Engineering (4 papers). Lauren Fong is often cited by papers focused on CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and CRISPR and Genetic Engineering (4 papers). Lauren Fong collaborates with scholars based in United States, Sweden and Netherlands. Lauren Fong's co-authors include Lawrence S.B. Goldstein, Dmitry Guschin, Edward J. Rebar, Josée Laganière, Philip D. Gregory, Xiangdong Meng, Dirk Hockemeyer, Vikram Khurana, Susan Lindquist and Lawrence I. Golbe and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Lauren Fong

14 papers receiving 989 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations

2011 555 citations Frank Soldner, Josée Laganière et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lauren Fong United States	8	743	255	212	134	103	14	1.0k
Emmanouil Metzakopian United Kingdom	17	969 1.3×	137 0.5×	272 1.3×	158 1.2×	140 1.4×	32	1.3k
Ferrill F. Rose United States	9	1.2k 1.6×	196 0.8×	220 1.0×	135 1.0×	101 1.0×	12	1.4k
Priya Srikanth United States	13	589 0.8×	247 1.0×	218 1.0×	92 0.7×	38 0.4×	16	866
Andrzej Swistowski United States	14	737 1.0×	132 0.5×	240 1.1×	56 0.4×	49 0.5×	17	903
Françoise Piguet France	13	481 0.6×	143 0.6×	232 1.1×	207 1.5×	56 0.5×	28	743
April M. Weissmiller United States	16	584 0.8×	213 0.8×	174 0.8×	65 0.5×	90 0.9×	30	926
Sol M. Reyna United States	7	793 1.1×	510 2.0×	344 1.6×	60 0.4×	59 0.6×	8	1.2k
Matheus B. Victor United States	12	877 1.2×	324 1.3×	359 1.7×	68 0.5×	122 1.2×	16	1.4k
Ningzhe Zhang United States	13	823 1.1×	124 0.5×	531 2.5×	54 0.4×	126 1.2×	13	985
Francesco Paonessa Italy	12	584 0.8×	131 0.5×	135 0.6×	101 0.8×	33 0.3×	18	870

Countries citing papers authored by Lauren Fong

Since Specialization

Citations

This map shows the geographic impact of Lauren Fong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren Fong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren Fong more than expected).

Fields of papers citing papers by Lauren Fong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren Fong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren Fong. The network helps show where Lauren Fong may publish in the future.

Co-authorship network of co-authors of Lauren Fong

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren Fong. A scholar is included among the top collaborators of Lauren Fong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren Fong. Lauren Fong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Abujarour, Ramzey, Mochtar Pribadi, Lauren Fong, et al.. (2024). A chemical approach facilitates CRISPRa-only human iPSC generation and minimizes the number of targeted loci required. Future Science OA. 10(1). FSO964–FSO964. 2 indexed citations

Pan, Yijia, Brian Groff, Rina M. Mbofung, et al.. (2022). Alloimmune Defense Receptor Harnesses Host Immune Cell Activation to Potentiate Functional Persistence and Anti-Tumor Activity of Off-the-Shelf, Cell-Based Cancer Therapy. Blood. 140(Supplement 1). 4547–4548. 7 indexed citations

Pan, Yijia, Brian Groff, Rina M. Mbofung, et al.. (2021). A Novel Stealth Strategy That Activates Adoptively Transferred Allogeneic Immune Cells and Avoids Rejection for Off-the-Shelf Cell-Based Cancer Therapy. Blood. 138(Supplement 1). 4800–4800. 1 indexed citations

Goulding, John, Mochtar Pribadi, Robert Blum, et al.. (2020). 114 Preclinical development of a novel iPSC-derived CAR-MICA/B NK cell immunotherapy to overcome solid tumor escape from NKG2D-mediated mechanisms of recognition and killing. SHILAP Revista de lepidopterología. A70.2–A71. 1 indexed citations

Bjordahl, Ryan, John Goulding, Mochtar Pribadi, et al.. (2020). Development of a Novel MICA/B-Specific CAR As a Pan-Tumor Targeting Strategy for Off-the-Shelf, Cell-Based Cancer Immunotherapy. Blood. 136(Supplement 1). 5–6. 2 indexed citations

Kant, Rik van der, Vanessa F. Langness, Cheryl Herrera, et al.. (2019). Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons. Cell stem cell. 24(3). 363–375.e9. 231 indexed citations

Bjordahl, Ryan, Svetlana Gaidarova, Karrune Woan, et al.. (2019). FT538: Preclinical Development of an Off-the-Shelf Adoptive NK Cell Immunotherapy with Targeted Disruption of CD38 to Prevent Anti-CD38 Antibody-Mediated Fratricide and Enhance ADCC in Multiple Myeloma When Combined with Daratumumab. Blood. 134(Supplement_1). 133–133. 13 indexed citations

Young, Jessica E., Lauren Fong, Harald Frankowski, et al.. (2018). Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer’s Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein. Stem Cell Reports. 10(3). 1046–1058. 71 indexed citations

Fong, Lauren, Sol M. Reyna, Vanessa F. Langness, et al.. (2018). Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-β clearance in human astrocytes. Journal of Biological Chemistry. 293(29). 11341–11357. 48 indexed citations

10.

Soldner, Frank, Josée Laganière, Albert Cheng, et al.. (2011). Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations. Cell. 146(2). 318–331. 555 indexed citations breakdown →

11.

Cha, Edward, Adil Daud, Douglas G. McNeel, Richard Heller, & Lauren Fong. (2011). Systemic immune responses induced by intratumoral plasmid IL-12 electroporation in patients with melanoma.. Journal of Clinical Oncology. 29(15_suppl). 2574–2574. 1 indexed citations

12.

Söldner, F., Josée Laganière, Albert Cheng, et al.. (2011). Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations. Cell. 146(4). 659–659. 21 indexed citations

13.

Laganière, Josée, Adrian P. Kells, Dmitry Guschin, et al.. (2010). An Engineered Zinc Finger Protein Activator of the Endogenous Glial Cell Line-Derived Neurotrophic Factor Gene Provides Functional Neuroprotection in a Rat Model of Parkinson's Disease. Journal of Neuroscience. 30(49). 16469–16474. 56 indexed citations

14.

Fong, Lauren, Serena S. Kwek, Vinh Dao, et al.. (2010). Identification of novel prostate cancer-associated antigens through antibody profiling of prostate cancer patients treated with CTLA-4 blockade.. Journal of Clinical Oncology. 28(15_suppl). 2578–2578. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact